Back to Top

"One of today's leaders in investor relations and shareholder services"

Category Archives: Client News

Progressive Care Releases Open Letter to Shareholders

Open Letter to Shareholders Summarizes Recent Milestones

MIAMI, Jan. 16, 2018 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management, releases the following letter to Shareholders from the Company’s Chief Executive Officer, S. Parikh Mars:

Dear Progressive Care Shareholders,

We begin 2018 with optimism and an unflappable sense of purpose and urgency. We have worked steadily to lay a solid foundation upon which we can grow and flourish through an ever-changing healthcare environment. The company remained focused on its vision for the future of healthcare and innovative approach to shape the …

Continue Reading

Posted in Client News| Tagged |

Terra Tech Corp. to Webcast, Live, at VirtualInvestorConferences.com January 18

Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual VirtualInvestorConferences.com

IRVINE, Calif., Jan. 12, 2018 /PRNewswire/ — Terra Tech Corp. (OTCQX: TRTC), a vertically integrated cannabis-focused agriculture company today announced that Derek Peterson, Chief Executive Officer will present live at VirtualInvestorConferences.com on January 18, 2018 at 1:00pm Eastern.

DATE: Thursday January 18, 2018
TIME: 1:00 PM EST
LINK: https://tinyurl.com/0118prepr

This will be a live, interactive online event where investors are invited to ask the company questions in real-time – both in the presentation hall as well as the association’s “virtual trade booth.” If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.

It is recommended that investors pre-register and run the online system check to save time and receive event updates.

Learn more about the event at www.VirtualInvestorConferences.com.

Recent …

Continue Reading

Posted in Client News| Tagged |

PositiveID Corporation Discusses 2017 Highlights and 2018 Outlook and Growth Projections in New Interview with SmallCapVoice.com

AUSTIN, Texas, Jan. 11, 2018 (GLOBE NEWSWIRE) — SmallCapVoice.com, Inc. today announced it conducted a new audio interview with PositiveID Corporation (“PositiveID” or the “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics. The interview can be heard at https://smallcapvoice.com/blog/1-9-18-smallcapvoice-interview-with-positiveid-corporation-psid.

In the interview, William J. Caragol, Chairman and CEO of PositiveID, discussed 2017 highlights for the Company’s medical device, mobile labs, and molecular diagnostics product lines, and provided additional insight on the Company’s projected consolidated year-over-year revenue growth of more than 30% for the 2017 fourth quarter and 2018 first quarter.

PositiveID operates in three segments: Mobile Labs, comprised of its E-N-G Mobile Systems, Inc. subsidiary, a specialty vehicle manufacturer; Medical Devices, comprised of its Thermomedics subsidiary, which markets the Caregiver® non-contact thermometer; and Molecular Diagnostics, comprised of its ExcitePCR Corporation subsidiary, consisting of its FireflyDX family of products for real-time pathogen detection at the point-of-need/point-of-care.

SmallCapVoice.com is …

Continue Reading

Posted in Client News| Tagged |

Progressive Care Continues to Break Records with Over $20 Million in Sales

MIAMI, Jan. 10, 2018 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB:RXMD), through its subsidiary PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management, announces over $20 million in net revenues on approximately 225,000 prescriptions filled in 2017.

PharmCo, LLC filled over 19,500 prescriptions during the month of December, generating approximately $1.6 million in net revenues. Prescriptions filled increased by approximately 8% over the same month last year. The company also filled over $360,000 (not included in net revenues) worth of prescriptions for 340B entities in December, generating fees to the pharmacy of over $15,000.

The company has been successful in breaking records in 2017. The company …

Continue Reading

Posted in Client News| Tagged |

ChineseInvestor.com, Inc.’s CEO Warren Wang Provides Progress Report and Outlook for Investors in a New Audio Interview at SmallCapVoice.com

AUSTIN, Texas, Jan. 09, 2018 (GLOBE NEWSWIRE) — SmallCapVoice.com, Inc. (SCV) and ChineseInvestors.com, Inc. (OTCQB:CIIX) (‘CIIX’ or the ‘Company’), the premier financial information website for Chinese-speaking investors, today announced that a new audio interview with the Company is now available. The interview can be heard at https://smallcapvoice.com/blog/1-5-18-smallcapvoice-interview-with-chineseinvestors-com-inc-ciix.

ChineseInvestor.com, Inc.’s CEO Warren Wang, called in to SmallCapVoice.com to discuss the business model and new markets for the company, the recent news and milestones achieved in 2017, what investors can expect from the Company in 2018, and more. In December 2017 the Company announced plans to spin off its wholly-owned foreign enterprise, CBD Biotechnology Co. Ltd., and its wholly-owned subsidiary, ChineseHempOil.com, Inc., to be registered as a separate publically traded company allowing CIIX to focus on its new Cryptocurrency Division and its Core Financial Education Business.

In the interview, Mr. Wang stated, “2017 was a very big year for ChineseInvestors.com and its …

Continue Reading

Posted in Client News| Tagged |

Oncolix Initiates Patient Recruitment of Second Cohort of Prolanta™ Phase 1 Trial in Advanced Ovarian Cancer

Dosing expected to begin in 1Q18

HOUSTON, Jan. 08, 2018 (GLOBE NEWSWIRE) — Oncolix, Inc., (OTCQB:ONCX) announced today that the Company’s clinical site investigator has initiated patient recruitment for the second dosing group for the Prolanta™ Phase 1 clinical trial in patients with advanced ovarian cancer. Patient dosing is anticipated to begin during the first quarter of 2018. The drug supply for this dosing group is scheduled to be shipped to the clinic from the contract manufacturer during January.

“Initiating patient recruitment of the second dosing group of our first Prolanta™ clinical trial is an important milestone for the company,” said Michael T. Redman, chief executive officer of Oncolix. “Recently, we have been focused on meeting our objectives to strengthen our public company infrastructure. Now we are moving forward with our primary objective and core value driver, which is to evaluate Prolanta™ in ovarian cancer patients with the ultimate goal …

Continue Reading

Posted in Client News| Tagged |